The Medical Devices Reports Bundle includes the following TriMark Publications reports at a 15% discount off the individual reports being purchased separately:
- Cardiac Rhythm Management Devices World Markets.
- Catheter Markets.
- Disposable Medical Supplies Markets.
- Disposable Syringe Markets.
- Home Medical Testing Devices.
- Orthopedics Markets.
- Patient Monitoring Markets.
- Plastic Surgery Markets.
- Respiratory Therapeutics and Devices Markets.
- Sleep Disorders.
Below are summaries of each report, along with a link to download a product sample which includes: detailed table of contents, writer's background, executive summary, report methodology and sample pages. All Report Bundles are available for purchase by invoice directly from TriMark. Add to cart and follow purchasing directions.
This TriMark Publications report reviews the worldwide cardiac rhythm management market size for the U.S., European and Asian markets. Individual country markets such as Japan, the Philippines, Australia, and the Middle East are covered. Important regulatory issues that impact the use of cardiac rhythm devices are explored for countries like the U.S., Japan, Australian, Korea, India, China, Israel, the Philippines, and those in the E.U. Reimbursement strategies for the U.S. Medicare program and European and Japanese medical insurance programs are discussed. Also, a summary of current legal proceedings in this industry, which are often used for competitive purposes, is provided. It focuses sales and market trends for pacemakers, defibrillators, leads, and other related cardiac rhythm devices. The cardiac rhythm management markets are divided into the segments of: external defibrillators, implantable defibrillators, external pacemakers, implantable pacemakers, and defibrillator and pacemaker electrodes and leads heart failure specialty products.
Catheters are used in a number of processes, such as: cardiovascular, urological, intravenous, oximetry, thermodilution, suction and wound drainage processes, that involve the administration or drainage of fluids from the body. The global market for catheters is vibrant and continually evolving with significant investments to improve the capabilities of existing catheters, improve safety features and identify new medical applications. The growing number of aged people undergoing diagnostic and therapeutic procedures is driving increases in catheter sales. Government regulations also play a key role, mainly in the urological catheter segment, as regulations attempt to promote fewer infections among hospitalized patients through more frequent use of catheterization. This TriMark Publications report provides a detailed analysis of the global market for catheters, including central venous catheters (CVC), peripheral venous catheters (PVC), midline catheters (MC), hemodialysis catheters, pulmonary artery catheters, peripheral artery catheters and umbilical catheters. The study also analyzes almost all of the companies known to be marketing, manufacturing or developing catheter products in the U.S. and worldwide. Detailed tables, charts and figures are included with projected sales data by geographic region for the Americas, EMRA (Europe, the Middle East, Russia, Africa) and Asia-Pacific regions.
This TriMark Publications report is intended to provide basic marketing data pertaining to the U.S. and worldwide market segments of the disposable medical supplies market, including: surgical gowns, surgical drapes, isolation gowns, surgical and examination gloves, institutional incontinence disposables, operating room (OR) custom kits and trays, non-OR custom packs, shoe covers, masks, disposable coveralls and lab coats, headwear, protective eyewear, sterile wipes, swabs and mops. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Growth rates and sales projections are reported in units and U.S. dollars. Market shares are based on units and apply to the U.S. only.
This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses. The disposable syringe market segments are identified as: 1) total reusable needle and syringe market; 2) total disposable needle and syringe market; 3) prefilled syringes; 4) safety syringes; 5) insulin injector pens; 6) needleless injectors; 7) vaccination injectors; 8) blood collection needles and syringes; 9) hypodermic needles and syringes market; 10) insulin needles and syringes market; 11) specialty needles and syringes market; and 12) needleless injector market.
Home healthcare is defined by the U.S. Centers for Disease Control and Prevention's (CDC) National Center for Health Statistics as, healthcare provided to individuals and families in their places of residence for the purpose of promoting, maintaining, or restoring health or for maximizing the level of independence while minimizing the effects of disability and illness, including terminal illness. Last year, an estimated 18 million people received home healthcare in the U.S., and most of these individuals also used associated home care products. With the aging of the "baby boom" generation and the increase in patient life spans--a trend not limited to the U.S.--the numbers of home care patients will continue to grow. As patient life spans are extended with more sophisticated medical care and new technologies, and home care becomes an increasingly important and accepted means to contain healthcare costs for managed care providers, this market segment is poised for significant growth in the near future. The purpose of this TriMark Publications report is to describe the specific segment of the home medical testing devices markets, with particular emphasis on the United States market. The U.S. market for home care products, testing, devices and equipment continues to post steady gains, primarily as a result of: 1) the aging population, 2) a growing trend to out-patient care and the corresponding shift of chronic care patients from hospitals, and 3) extended care facilities to the home. In other areas of the world, the results vary depending on the economies of the country and the health sophistication of the consuming public. This analysis presents an overview of the home medical testing devices market with the latest information regarding emerging new products, new markets for older products/technologies and industry trends.
Orthopedics is a medical specialty that deals with the diagnosis and treatment of disorders and injuries to the skeletal system and the muscles, joints and ligaments associated with it. The orthopedics market has emerged as one of the most vibrant industries in the medical equipment sector. In the recent past, the orthopedics industry has witnessed major private equity transactions, several notable mergers and innovative product launches. As such, the orthopedics market has been experiencing a growth rate of nearly 5% to 7% annually. Five market leaders currently dominate the global market, each with about $2 billion or more in annual sales. The purpose of this TriMark Publications report is to provide a detailed analysis of the global market for orthopedics. The product segments covered in study include: reconstructive devices, fracture repair, arthroscopy/tissue repair, spinal implants/instrumentation, orthobiologics and other orthopedic products. The study analyzes almost all of the companies known to be marketing, manufacturing or developing orthopedic products in the U.S. and worldwide. Each company is discussed in depth, with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Also provided in this review are detailed tables, charts and figures with past and projected sales data by geographic region for the U.S., EMEA (Europe, Middle East, Africa), Japan, the Pacific Rim, Canada and Latin America.
Patient monitoring is vital to care in operating rooms, emergency rooms, intensive care units and critical care units. It has proven invaluable for respiratory therapy, recovery rooms, outpatient care, transport, radiology, catheterization laboratories and gastroenterology departments, as well as for ambulatory, home and sleep screening applications. Patient monitoring can reduce the risk of infection and other complications, and it can assist in providing for patient comfort. Moreover, patient monitoring products measure, display and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices. The qualifier "at regular intervals over time" is used to distinguish patient monitoring devices from diagnostic kits and devices, which are typically used once or a few times to diagnose a patient's condition and/or plan a course of therapy. Measured parameters include electrocardiogram (ECG), invasive and noninvasive blood pressure, pulse rate, pulse oximetry, body temperature, respiration rate, end-tidal CO2 and other specialized parameters. Products vary from specialized single-parameter instruments to monitors with the ability to measure multiple parameters and interface with other instruments. This TriMark Publications report assesses the patient monitoring device market drivers and bottlenecks from the perspective of medical and manufacturer communities; discusses the potential benefits of the patient monitoring device market for various sectors of the medical community; establishes the current total market size and future growth of the patient monitoring device market and analyzes the current size and growth of various segments; provides current and forecasted market shares by the company; provides strategic recommendations for near-term business opportunities and assesses current commercial uses of the patient monitoring market.
Modern advances in plastic surgery have allowed patients with severe physical deformities to live normal lives. Where at one time an individual suffering from an extreme physical abnormality simply had to "live with it," plastic surgical techniques can now ameliorate or even completely correct the original physical ailment. Beyond addressing serious physical handicaps, plastic surgery for purely cosmetic reasons has exploded around the world. For the purposes of this report, the term "plastic surgery" is divided into two distinct groups: 1) reconstructive surgery focused on restoring normal physical function resulting from an abnormality or injury to the body and 2) cosmetic surgery focused on simply improving one's physical appearance. Moreover, this study provides a comprehensive analysis of the trends in medical tourism to seek lower-cost procedures, advances in minimally-invasive surgical techniques that can be performed on an out-patient basis in doctors' and dentists' offices, and purchases of over-the-counter beauty products, such as traditional cosmetic makeup and new non-invasive devices, marketed to consumers who wish to change their physical appearance without surgery.
In the respiratory therapeutics and devices market, continuing new advancements in the ability to detect and manage respiratory diseases are being made. The respiratory disease space is one of the most profitable sectors of therapeutics, and it is expected to be growing vigorously into the future. This TriMark Publications report analyzes various respiratory therapeutics and devices markets, with special attention paid to therapeutic remedies for chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis. Also addressed in this study are therapeutics for upper respiratory infections such as: allergic rhinitis, influenza, respiratory syncytial virus, sinusitis, and pharyngitis/tonsillitis. From respiratory devices side, key segments covered include: continuous positive airway pressure (CPAP) devices, ventilators, nebulizers, oxygen concentrators, humidifiers and reusable resuscitators. This review covers the leading market players, the competitive landscape, and the emerging pipeline products in the respiratory therapeutics and devices markets. Specifically, areas examined in this study include: available and developing technologies in the field, the U.S. and global market size for respiratory therapeutic products, and the profiles of companies that are focusing on the respiratory therapeutics and devices market. This review analyzes the size and growth of the therapeutic respiratory disease category, including the factors that influence the various market segments within it. Detailed charts with sales forecasts and market share data for the U.S. and global respiratory therapeutics and devices markets are included.
Insomnia, sleep apnea, restless leg syndrome, bruxism, narcolepsy and sleepwalking are all serious sleep disorders that possess negative--and sometimes fatal--health consequences. Often undiagnosed and thus not treated, sleep disorders can not only take a toll on personal health but can also adverse effects on personal relationships and reduce worker productivity. In examining the troubling increase in a variety of sleep disorders, this TriMark Publications report will analyze the causes and available treatments for sleep disorder sufferers. This is a particularly interesting time in the evolution of the sleep disorders market because the blockbuster drugs that have dominated this space are coming off patent protection. There has been a strong push on the part of the major pharmaceutical companies to develop or acquire replacement sources of revenue. In order to put sleep disorders in a proper context, the study begins with an examination of key characteristics of the overall sleep disorders market. The types of disorders, causes of insomnias, parasomnias and their treatments are analyzed, with the additional review of treatments including pharmaceuticals, devices (continuous positive airway pressure or CPAP machines) and others (nutraceuticals, etc.). The report goes on to describe the primary product offerings of the major companies in this market space including major classes of prescription and over-the-counter (OTC) pharmaceuticals. Finally, a review of companies developing treatments for insomnia, sleep apnea, restless leg syndrome, bruxism, narcolepsy and sleepwalking are examined.